These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9836189)

  • 1. Studies on cell-specific cytotoxicities induced by p-aminophenyl-mercuric acetate (APMA).
    Kim HM; Hong DH; Lee CW; Kim YH; Kim MS; Lee HY; Han SB
    J Toxicol Sci; 1998 Oct; 23 Suppl 4():653-6. PubMed ID: 9836189
    [No Abstract]   [Full Text] [Related]  

  • 2. The organomercurial 4-aminophenylmercuric acetate, independent of matrix metalloproteinases, induces dose-dependent activation/inhibition of platelet aggregation.
    Rosenfeldt MT; Valentino M; Labruzzo S; Scudder L; Pavlaki M; Cao J; Vacirca J; Bahou WF; Zucker S
    Thromb Haemost; 2005 Feb; 93(2):326-30. PubMed ID: 15711750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous propeptide processing of mini-stromelysin-1 mutants blocked by APMA ((4-Aminophenyl)mercuric acetate).
    Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
    Biochemistry; 1999 Jan; 38(4):1316-22. PubMed ID: 9930993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate.
    Nagase H; Enghild JJ; Suzuki K; Salvesen G
    Biochemistry; 1990 Jun; 29(24):5783-9. PubMed ID: 2383557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modulation with phorbol myristate acetate and staurosporine of interleukin 2- induced proliferation and nonspecific cytotoxicity of rat lymphocytes].
    Anisimov AG; Bolotnikov IA
    Biull Eksp Biol Med; 1996 Oct; 122(10):394-8. PubMed ID: 9081434
    [No Abstract]   [Full Text] [Related]  

  • 6. APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide.
    Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
    Biochemistry; 1996 Aug; 35(34):11221-7. PubMed ID: 8780527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of immunosuppressives on gamma-interferon production, lymphocyte proliferation, and cytotoxic function of activated T lymphocytes.
    Bishop GA; Hall BM
    Transplant Proc; 1987 Apr; 19(2):2866-8. PubMed ID: 3105124
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 9. Equine laminitis: glucose deprivation and MMP activation induce dermo-epidermal separation in vitro.
    French KR; Pollitt CC
    Equine Vet J; 2004 Apr; 36(3):261-6. PubMed ID: 15147135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and inhibition of endogenous matrix metalloproteinases in articular cartilage: effects on composition and biophysical properties.
    Bonassar LJ; Stinn JL; Paguio CG; Frank EH; Moore VL; Lark MW; Sandy JD; Hollander AP; Poole AR; Grodzinsky AJ
    Arch Biochem Biophys; 1996 Sep; 333(2):359-67. PubMed ID: 8809074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3).
    Arza B; De Maeyer M; Félez J; Collen D; Lijnen HR
    Eur J Biochem; 2001 Feb; 268(3):826-31. PubMed ID: 11168424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for studying activation of matrix metalloproteinases.
    Knäuper V; Murphy G
    Methods Mol Biol; 2001; 151():377-87. PubMed ID: 11217313
    [No Abstract]   [Full Text] [Related]  

  • 14. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
    Itoh Y; Binner S; Nagase H
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological analysis of proteoglycan structural changes in the early stage of experimental osteoarthritic canine cartilage lesions.
    Pelletier JP; Martel-Pelletier J; Mehraban F; Malemud CJ
    J Orthop Res; 1992 Jul; 10(4):511-23. PubMed ID: 1377239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of matrix metalloproteinases against matrix substrates.
    Cawston TE; Koshy P; Rowan AD
    Methods Mol Biol; 2001; 151():389-97. PubMed ID: 11217314
    [No Abstract]   [Full Text] [Related]  

  • 17. The interaction of IL-2 and IL-4 with the effects of deoxyspergualin.
    Kerr PG; Atkins RC
    Transplant Proc; 1990 Oct; 22(5):2121-2. PubMed ID: 2219316
    [No Abstract]   [Full Text] [Related]  

  • 18. Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1).
    Chen LC; Noelken ME; Nagase H
    Biochemistry; 1993 Oct; 32(39):10289-95. PubMed ID: 8399171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive mechanism of action of deoxymethylspergualin--a human in vitro assay.
    Takano Y; Takahara S; Jiang H; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A
    Transplant Proc; 1992 Aug; 24(4):1372-4. PubMed ID: 1386697
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential inhibition of lymphocyte function by 2-chloroadenosine.
    Nishida Y; Kamatani N; Morito T; Miyamoto T
    Int J Immunopharmacol; 1984; 6(4):335-8. PubMed ID: 6480196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.